What makes analysts so bullish about these three names from the sector?
These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...
DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...
USA News Group – Before the global health crisis began at the beginning of 2020, 1 in 5 adults were receiving mental health treatment. As society emerges from the last two and a half years of disruptions,...
NetworkNewsWire Editorial Coverage : Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of the nervous system to change...
NetworkNewsWire Editorial Coverage  New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability...